Health wellness company focusing on integrating functional mushrooms products and making psychedelics products easily available to those in need Optimi Heath Corp. (CSE: OPTI) (OTC: OPTHF) has joined the first ever psychedelics exchange traded fund (ETF).
This first psychedelics exchange traded fund stated trading on the NEO Exchange from the first month of the year. Optimi Health becomes the latest entry in the list of 23 companies in the ETF which have met the requirement needed to list with the ETF.
The EFT aims to replicate the performance of a market index designed to provide exposure to the performance of a group of North America based and publicly listed psychedelics companies.
“Inclusion into the ETF is a significant milestone for Optimi Health’s stakeholders. The recognition the Horizons ETF brings us is certainly advantageous to the Company and the increased visibility alone is a big plus, providing increased confidence and assurance to the newer investors. While the ETF brings additional exposure to potential new investors, it also generates value for existing shareholders. We are incredibly pleased to make this announcement today and look forward to capitalizing upon this outstanding opportunity as quickly as possible,” said Optimi’s CEO, Mike Stier.
